Wound Infection
Conditions
Brief summary
All patients with deep venous obstruction below the sapheno-femoral junction elective for hybrid procedure with creation of an arterio venous-fistula (AVF) in the MUMC or patients with primary percutaneous procedure (and thus venous obstruction above the sapheno-femoral junction) who present with occluded stents which need an additional AVF after thrombolysis will receive a Prevena NPWT. Incidence of wound infections and wound scoring will be performed afterwards.
Interventions
DEVICEPrevena, KCI, Acelity, NPWT
All patients will receive a Prevena NPWT (if inclusion criteria are met)
Sponsors
Maastricht University Medical Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* All patients with deep venous obstruction below the sapheno-femoral junction primary elective for hybrid procedure with creation of an AV-fistula in the MUMC * Be able to communicate in Dutch * Life expectancy \>1 year
Exclusion criteria
* Patients with allergies for the components of the used negative pressure incision management system (Prevena)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Patients With wound infections or Adverse Events That Are Related to Prevena incision management negative pressure wound therapy | 3 months | Patients will be prospectively followed and checked for development of wound infections (grade 1-5). Therapy to treat the infections will be monitored. |
Countries
Netherlands
Contacts
Primary ContactTimme van Vuuren, MD
Backup ContactJ. van Laanen, MD
Outcome results
None listed